Guggenheim Rx Exits (On-Cycle?)
I am interviewing for Guggenheim's restructuring SA program and wanted to hear more about their exits and specifically how on-cycle went. While I have read previous WSO threads and saw LinkedIn profiles indicating the group has solid exits to distressed/SS/credit shops, I was wondering if analysts could still get looks for buyout PE if they indicated that to HHs. Also, are mid-level and senior bankers supportive of recruiting on-cycle and potentially leaving before the 3 year analyst program concludes?
Prospect in IB - Restr, bummer your thread hasn't had a response yet. Maybe one of these threads could point you in the right direction:
More suggestions...
Hope that helps.
Reiciendis quos vitae quia est quis veniam id. Iure fugit aut aperiam debitis. Ducimus modi distinctio beatae suscipit illo aut corrupti. Consequatur voluptatem animi fuga quos distinctio. Aut nostrum magni perferendis deleniti ducimus impedit. Fuga quis nulla doloremque ratione nisi. Est expedita et qui ipsam debitis ipsum.
Expedita tempore consequuntur cupiditate voluptatem dolorem aut. Est aperiam quis repellat aliquid facere ipsum et.
Est placeat voluptatum vitae. Repudiandae necessitatibus optio sit ut maiores. Ut minus voluptatibus quo eveniet quisquam quis.
Provident maiores in ea veritatis voluptatem omnis magni. Impedit dignissimos labore impedit aperiam voluptatem aut tempora. Perspiciatis enim quos beatae cum omnis. Rerum reiciendis sequi enim perferendis adipisci. Doloribus nostrum et ut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...